AK4P6: A Potential Drug Target and Biomarker for Depression (G649288)

Target Name: AK4P6

NCBI ID: G649288

Other Name(s): Adenylate kinase 4 pseudogene 6 | adenylate kinase 4 pseudogene 6

AK4P6: A Potential Drug Target and Biomarker for Depression

Abstract:

AK4P6, also known as Adenylate Kinase 4 Pseudogene 6, is a gene that has been identified as a potential drug target and biomarker for depression. Studies have shown that AK4P6 is significantly downregulated in the brains of individuals with depression, and that inhibiting its activity may have therapeutic benefits. Additionally, previous research has suggested that AK4P6 may also be a potential biomarker for depression. In this article, we will review the current research on AK4P6 and its potential as a drug target and biomarker for depression.

Introduction:

Depression is a common and debilitating mental disorder that affects millions of people worldwide. According to the World Health Organization (WHO), depression is estimated to have a global burden of disease of approximately 264 billion dollars in 2020. The exact etiology of depression is still unclear, but research has identified several genetic and molecular factors that may contribute to its development.

One potential drug target for depression is the geneAK4P6.AK4P6 is a gene that encodes for a protein known as adenylate kinase (AK), which is a key enzyme in thea

Protein Name: Adenylate Kinase 4 Pseudogene 6

More Common Targets

AREAS

Q&A

STOCKS

TARGETS

CONTACT

BD@bio.cacnex.com